Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Non-cash Items (2022 - 2025)

Neuroone Medical Technologies' Non-cash Items history spans 4 years, with the latest figure at $999882.0 for Q3 2025.

  • For Q3 2025, Non-cash Items rose 4307.68% year-over-year to $999882.0; the TTM value through Sep 2025 reached $999882.0, up 4307.68%, while the annual FY2025 figure was $999882.0, 4307.68% up from the prior year.
  • Non-cash Items reached $999882.0 in Q3 2025 per NMTC's latest filing, up from $22685.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $999882.0 in Q3 2025 to a low of $20064.0 in Q3 2023.
  • Average Non-cash Items over 4 years is $282981.5, with a median of $55990.0 recorded in 2022.
  • Peak YoY movement for Non-cash Items: plummeted 77.53% in 2023, then soared 4307.68% in 2025.
  • A 4-year view of Non-cash Items shows it stood at $89295.0 in 2022, then tumbled by 77.53% to $20064.0 in 2023, then increased by 13.06% to $22685.0 in 2024, then skyrocketed by 4307.68% to $999882.0 in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Non-cash Items are $999882.0 (Q3 2025), $22685.0 (Q3 2024), and $20064.0 (Q3 2023).